A detailed history of Russell Investments Group, Ltd. transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 620 shares of VRCA stock, worth $4,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
620
Previous 71 773.24%
Holding current value
$4,929
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$5.89 - $9.56 $3,233 - $5,248
549 Added 773.24%
620 $4,000
Q4 2023

Feb 05, 2024

BUY
$2.93 - $7.32 $208 - $519
71 New
71 $0

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.